文献速递肝病

改变SUN1降解的常见变异在多个队列中与肝脂肪变及代谢特征相关

A common variant that alters SUN1 degradation associates with hepatic steatosis and metabolic traits in multiple cohorts.
PubMed 文献 · J Hepatol · 2023-08-09

研究假设核膜相关基因常见变异参与肝脂肪变和NAFLD,在三个发现队列(N>120,000)中对核膜相关编码变异做关联Meta分析,并在验证队列(N>600,000)中做表型关联及细胞功能实验。常见编码变异rs6461378(SUN1 H118Y)为肝脂肪变关联最强变异(p<0.001),并在验证队列中与组织学NAFLD及代谢特征相关;该变异蛋白降解增加,表达细胞出现胰岛素抵抗和脂质蓄积。

要点

  • rs6461378(SUN1 H118Y)是肝脂肪变关联Meta分析中最强关联的常见编码变异(p<0.001)。
  • 在祖先不同的验证队列中,rs6461378与组织学NAFLD及NAFLD相关代谢特征相关。
  • SUN1 H118Y较野生型SUN1更易被蛋白酶体降解,表达该变异的细胞出现胰岛素抵抗和脂质蓄积增加。

核心结论

  • 这些数据支持常见SUN1变异rs6461378在NAFLD和代谢疾病中可能具有因果作用。
  • 若未来研究证实常见SUN1 H118Y变异的因果性,它有可能成为NAFLD和代谢疾病中广泛相关的治疗靶点。

研究设计与样本

  • 以肝脂肪变为结局,在三个大型发现队列(N>120,000名参与者)中对核膜相关编码变异进行关联Meta分析。
  • 随后在大型验证队列(N>600,000)中进行表型关联研究。
  • 并在细胞培养中对肝脂肪变关联最强的变异进行功能测试。

主要发现

  • 常见蛋白编码变异rs6461378(SUN1 H118Y)在关联Meta分析中是肝脂肪变关联最强的变异(p<0.001)。
  • 在祖先不同的验证队列中,rs6461378与组织学NAFLD相关,并与NAFLD相关代谢特征相关,包括血清脂肪酸升高、2型糖尿病、高血压、心血管疾病和HDL降低。
  • 在细胞中,SUN1 H118Y较野生型SUN1更易被蛋白酶体降解。
  • 表达SUN1 H118Y的细胞表现出胰岛素抵抗和脂质蓄积增加。

临床怎么用

  • 作者认为这些数据为将核膜特别是SUN1纳入NAFLD遗传学和病理生理学概念提供了依据。
  • 作者认为若未来研究证实常见SUN1 H118Y变异的因果性,它有可能成为NAFLD和代谢疾病中广泛相关的治疗靶点。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Non-alcoholic fatty liver disease (NAFLD), and its progressive form steatohepatitis (NASH), represent a genetically and phenotypically diverse entity for which there is no approved therapy, making it imperative to define the spectrum of pathways contributing to its pathogenesis. Rare variants in genes encoding nuclear envelope proteins cause lipodystrophy with early-onset NAFLD/NASH; we hypothesized that common variants in nuclear envelope-related genes might also contribute to hepatic steatosis and NAFLD. METHODS: Using hepatic steatosis as the outcome of interest, we performed an association meta-analysis of nuclear envelope-related coding variants in three large discovery cohorts (N >120,000 participants), followed by phenotype association studies in large validation cohorts (N >600,000) and functional testing of the top steatosis-associated variant in cell culture. RESULTS: A common protein-coding variant, rs6461378 (SUN1 H118Y), was the top steatosis-associated variant in our association meta-analysis (p <0.001). In ancestrally distinct validation cohorts, rs6461378 associated with histologic NAFLD and with NAFLD-related metabolic traits including increased serum fatty acids, type 2 diabetes, hypertension, cardiovascular disease, and decreased HDL. SUN1 H118Y was subject to increased proteasomal degradation relative to wild-type SUN1 in cells, and SUN1 H118Y-expressing cells exhibited insulin resistance and increased lipid accumulation. CONCLUSIONS: Collectively, these data support a potential causal role for the common SUN1 variant rs6461378 in NAFLD and metabolic disease. IMPACT AND IMPLICATIONS: Non-alcoholic fatty liver disease (NAFLD), with an estimated global prevalence of nearly 30%, is a growing cause of morbidity and mortality for which there is no approved pharmacologic therapy. Our data provide a rationale for broadening current concepts of NAFLD genetics and pathophysiology to include the nuclear envelope, and particularly Sad1 and UNC84 domain containing 1 (SUN1), as novel contributors to this common liver disease. Furthermore, if future studies confirm causality of the common SUN1 H118Y variant, it has the potential to become a broadly relevant therapeutic target in NAFLD and metabolic disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Upadhyay KK, Du X, Chen Y, et al. A common variant that alters SUN1 degradation associates with hepatic steatosis and metabolic traits in multiple cohorts. J Hepatol. 2023. PMID: 37567366. doi:10.1016/j.jhep.2023.07.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。